PharmacoEconomics

, Volume 25, Issue 1, pp 7–24

Reducing the Societal Burden of Depression

A Review of Economic Costs, Quality of Care and Effects of Treatment
Review Article

Abstract

Depression is a highly prevalent condition that results in substantial functional impairment. Advocates have attempted in recent years to make the ‘business case’ for investing in quality improvement efforts in depression care, particularly in primary care settings. The business case suggests that the costs of depression treatment may be offset by gains in worker productivity and/or reductions in other healthcare spending. In this paper, we review the evidence in support of this argument for improving the quality of depression treatment.

We examined the impact of depression on two of the primary drivers of the societal burden of depression: healthcare utilisation and worker productivity. Depression leads to higher healthcare utilisation and spending, most of which is not the result of depression treatment costs. Depression is also a leading cause of absenteeism and reduced productivity at work. It is clear that the economic burden of depression is substantial; however, critical gaps in the literature remain and need to be addressed. For instance, we do not know the economic burden of untreated and/or inappropriately treated versus appropriately treated depression.

There remain considerable problems with access to and quality of depression treatment. Progress has been made in terms of access to care, but quality of care is seldom consistent with national treatment guidelines. A wide range of effective treatments and care programmes for depression are available, yet rigorously tested clinical models to improve depression care have not been widely adopted by healthcare systems. Barriers to improving depression care exist at the patient, healthcare provider, practice, plan and purchaser levels, and may be both economic and non-economic.

Studies evaluating interventions to improve the quality of depression treatment have found that the cost per QALY associated with improved depression care ranges from a low of $US2519 to a high of $US49 500. We conclude from our review of the literature that effective treatment of depression is cost effective, but that evidence of a medical or productivity cost offset for depression treatment remains equivocal, and this points to the need for further research in this area.

References

  1. 1.
    Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and morbidity from diseases, injury and risk factors in 1990 and projected to 2020. Cambridge (MA): Harvard University Press, 1996Google Scholar
  2. 2.
    Ustun TB, Ayuso-Mateos JL, Chatterji S, et al. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386–392PubMedCrossRefGoogle Scholar
  3. 3.
    Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psych 2003; 64 (12): 1465–1473CrossRefGoogle Scholar
  4. 4.
    Panzarino Jr PJ. The costs of depression: direct and indirect; treatment versus nontreatment. J Clin Psych 1998; 59 Suppl. 20: 11–14Google Scholar
  5. 5.
    Pincus HA, Pettit AR. The societal costs of chronic major depression. J Clin Psych 2001; 62 Suppl. 6: 5–9Google Scholar
  6. 6.
    Thompson D Richardson E. Current issues in the economics of depression management. Curr Psychiatry Rep 1999; 1: 125–134PubMedCrossRefGoogle Scholar
  7. 7.
    Schulberg HC, Katon W, Simon GE, et al. Treating major depression in primary care: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psych 1998; 55: 1121–1127CrossRefGoogle Scholar
  8. 8.
    Hirschfield RMA, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997; 277 (4): 333–340CrossRefGoogle Scholar
  9. 9.
    US Department of Health and Human Services. Mental health: a report of the Surgeon General. Rockville (MD): US Department of Health and Human Services, 1999Google Scholar
  10. 10.
    Regier DA, Hirschfeld RMA, Goodwin FK, et al. The NIMH depression awareness, recognition, and treatment programs: structure, aims, and scientific basis. Am J Psychiatry 1998; 145 (11): 1351–1357Google Scholar
  11. 11.
    Pincus HA, Hough L, Knox-Houtsinger J, et al. Emerging models of depression care: multi-level (‘6P’) strategies. Int J Methods Psychiatr Res 2003; 12 (1): 54–63PubMedCrossRefGoogle Scholar
  12. 12.
    Young AS, Klap R, Sherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psych 2001; 58 (1): 55–61CrossRefGoogle Scholar
  13. 13.
    Meredith LA. Depression:20 years of progress. Med Care 2004; 42 (6): 499–501Google Scholar
  14. 14.
    Pincus HA. The future of behavioral health and primary care: drowning in the mainstream or left on the bank? Psychosomatics 2003; 44 (1): 1–11PubMedCrossRefGoogle Scholar
  15. 15.
    Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psych 1996; 53 (10): 924–932CrossRefGoogle Scholar
  16. 16.
    Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psych 2001; 58: 241–247CrossRefGoogle Scholar
  17. 17.
    Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 1995; 273 (13): 1026–1031PubMedCrossRefGoogle Scholar
  18. 18.
    Katzelnick DJ, Simon GE, Pearson SD, et al. Randomized trial of a depression management program in high utilizers of medical care. Arch Fam Med 2000; 9: 345–351PubMedCrossRefGoogle Scholar
  19. 19.
    Rost K, Nutting PA, Smith J, et al. Designing and implementing a primary care intervention trial to improve the quality and outcome of care for major depression. Gen Hosp Psych 2000; 22: 66–77CrossRefGoogle Scholar
  20. 20.
    Schulberg HC, Block MR, Madonia MJ, et al. Treating major depression in primary care practice: eight-month clinical outcomes. Arch Gen Psych 1996; 53 (10): 913–919CrossRefGoogle Scholar
  21. 21.
    Sherbourne CD, Wells KB, Duan N, et al. Long-term effectiveness of disseminating quality improvement for depression in primary care. Arch Gen Psych 2001; 58: 696–703CrossRefGoogle Scholar
  22. 22.
    Unutzer J, Rubenstein L, Katon WJ, et al. Two-year effects of quality improvement programs on medication management for depression. Arch Gen Psych 2001; 58 (10): 935–942CrossRefGoogle Scholar
  23. 23.
    Wells KB, Sherbourne C, Shoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA 2000; 283 (2): 212–220PubMedCrossRefGoogle Scholar
  24. 24.
    Langlieb AM, Kahn JP. How much does quality mental health care profit employers? J Occup Environ Med 2005; 47 (11): 1099–1109PubMedCrossRefGoogle Scholar
  25. 25.
    Goetzel RZ, Ozminkowski RJ, Sederer LI, et al. The business case for quality mental health services: why employers should care about the mental health and well-being of their employees. J Occup Environ Med 2002; 44 (4): 320–330PubMedCrossRefGoogle Scholar
  26. 26.
    Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psych 2005; 62: 617–627CrossRefGoogle Scholar
  27. 27.
    Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder:results from the National Comorbidity Survey Replication(NCS-R). JAMA 2003; 289 (23): 3095–3105PubMedCrossRefGoogle Scholar
  28. 28.
    Andrade L, Caraveo-Anduaga JJ, Berglund P, et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) survey. Int J Methods Psychiatr Res 2003; 12 (1): 3–21PubMedCrossRefGoogle Scholar
  29. 29.
    Goldney R, Hawthorne G, Fisher L, et al. Is the Australian National Survey of Mental Health and Wellbeing a reliable guide for health planners? A methodological note on the prevalence of depression. Aust N Z J Psychiatry 2004; (38): 635–638CrossRefGoogle Scholar
  30. 30.
    Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe: a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357–376PubMedCrossRefGoogle Scholar
  31. 31.
    Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. JAMA 1989; 262: 914–919PubMedCrossRefGoogle Scholar
  32. 32.
    Katon WJ, Shoenbaum M, Fan MY, et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch Gen Psych 2005; 62 (12): 1313–1320CrossRefGoogle Scholar
  33. 33.
    Rost K, Pyne JM, Dickinson LM, et al. Cost-effectiveness of enhancing primary care depression management on an ongoing basis. Ann Fam Med 2005; 3: 7–14PubMedCrossRefGoogle Scholar
  34. 34.
    Pyne JM, Rost KM, Zhang M, et al. Cost-effectiveness of a primary care depression intervention. J Gen Int Med 2003; 18 (6): 432–441CrossRefGoogle Scholar
  35. 35.
    Simon GE, Von Korff M, Ludman EJ, et al. Cost-effectiveness of a program to prevent depression relapse in primary care. Med Care 2002; 40 (10): 941–950PubMedCrossRefGoogle Scholar
  36. 36.
    Simon GE, Manning WG, Katzelnick DJ, et al. Cost-effectiveness of systematic depression treatment for high utilizers of general medical Care. Arch Gen Psych 2001; 58: 181–187CrossRefGoogle Scholar
  37. 37.
    Schoenbaum M, Unutzer J, Sherbourne C, et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA 2001; 286 (11): 1325–1330PubMedCrossRefGoogle Scholar
  38. 38.
    Lave JR, Frank RG, Schulberg HC, et al. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psych 1998; 55: 645–651CrossRefGoogle Scholar
  39. 39.
    Von Korff M, Katon W, Bush T, et al. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med 1998; 60 (2): 143–149Google Scholar
  40. 40.
    Greenberg P, Corey-Lisle PK, Birnbaum H, et al. Economic implications of treatment-resistant depression among employees. Pharmacoeconomics 2004; 22 (6): 363–373PubMedCrossRefGoogle Scholar
  41. 41.
    Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psych 1993; 54 (11): 405–418Google Scholar
  42. 42.
    Stoudemire A, Frank R, Hedemark N, et al. The economic burden of depression. Gen Hosp Psych 1986; 8: 387–394CrossRefGoogle Scholar
  43. 43.
    Rice DP, Miller LS. The economic burden of affective disorders. Br J Psychiatry 1995; 166 Suppl. 27: 34–42Google Scholar
  44. 44.
    Druss B, Rosenheck R, Sledge W. Health and disability costs of depressive illness in a major US corporation. Am J Psych 2000; 157 (8): 1274–1278CrossRefGoogle Scholar
  45. 45.
    Russell JM, Hawkins K, Ozminkowski RJ, et al. The cost consequences of treatment-resistant depression. J Clin Psych 2004; (65): 341–347CrossRefGoogle Scholar
  46. 46.
    Croghan T, Obenchain RL, Crown WE. What does treatment of depression really cost? Health Aff 1998; 17: 198–208CrossRefGoogle Scholar
  47. 47.
    Simon GE, Von Korff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psych 1995; 52: 850–856CrossRefGoogle Scholar
  48. 48.
    Simon GE, Von Korff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995; 152: 352–357PubMedGoogle Scholar
  49. 49.
    Unutzer J, Patrick DL, Simon G, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: a 4 year prospective study. JAMA 1997; 277: 1618–1623PubMedCrossRefGoogle Scholar
  50. 50.
    Katon WJ, Lin E, Russo J, et al. Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psych 2003; 60: 897–903CrossRefGoogle Scholar
  51. 51.
    Goetzel RZ, Anderson DR, Whitmer W, et al. The relationship between modifiable health risks and health care expenditures: an analysis of the multi-employer HERO health risk and cost database. J Occup Environ Med 1998; 40 (10): 843–854PubMedCrossRefGoogle Scholar
  52. 52.
    Henk HJ, Katzelnick DJ, Kobak KA, et al. Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization. Arch Gen Psych 1996; 53 (10): 899–904CrossRefGoogle Scholar
  53. 53.
    Emptage NP, Sturm R, Robinson RL. Depression and comorbid pain as predictors of disability, employment, insurance status, and health care costs. Psychiatr Serv 2005; 56 (4): 468–474PubMedCrossRefGoogle Scholar
  54. 54.
    Shvartzman P, Weiner Z, Vardy D, et al. Health services utilization by depressive patients identified by the MINI questionnaire in a primary care setting. Scand J Prim Health Care 2005; 23: 18–25PubMedCrossRefGoogle Scholar
  55. 55.
    Berndt ER, Koran LM, Finkelstein SN, et al. Lost human capital from early-onset chronic depression. Am J Psychiatry 2000; 157 (6): 940–947PubMedCrossRefGoogle Scholar
  56. 56.
    Stewart WF, Ricci JA, Chee E, et al. Cost of lost productive work time among US workers with depression. JAMA 2003; 289: 3135–3144PubMedCrossRefGoogle Scholar
  57. 57.
    Rost K, Smith JL, Dickinson M. The effect of improving primary care depression management on employee absenteeism and productivity: a randomized trial. Med Care Dec 2004; 42 (12): 1202–1210CrossRefGoogle Scholar
  58. 58.
    Zhang M, Rost KM, Fortney JC, et al. A community study of depression treatment and employment earning. Psychiatr Serv 1999; 50 (9): 1209–1213PubMedGoogle Scholar
  59. 59.
    Zhang M, Rost KM, Fortney JC. Earnings changes for depressed individuals treated by mental health specialists. Am J Psychiatry 1999; 156 (1): 108–114PubMedGoogle Scholar
  60. 60.
    Kessler RC, Barner C, Birnbaum HG, et al. Depression in the workplace: effects on short-term disability. Health Aff 1999; 18 (5): 163–171CrossRefGoogle Scholar
  61. 61.
    Leon AC, Walkup JT, Porntera L. Assessment and treatment of depression in disability claimants: a cost-benefit simulation. J Nerv Ment Dis 2002; 190 (1): 3–9PubMedCrossRefGoogle Scholar
  62. 62.
    Collins JJ, Baase CM, Sharda CE, et al. The assessment of chronic health conditions on work performance, absence, and total economic impact for employers. J Occup Environ Med 2005; 47 (6): 547–557PubMedCrossRefGoogle Scholar
  63. 63.
    Himmelhoch S, Weller WE, Wu AW, et al. Chronic medical illness, depression and use of acute medical services among Medicare beneficiaries. Med Care 2004; 42 (6): 512–521CrossRefGoogle Scholar
  64. 64.
    Katon WJ, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res 2002; 53: 859–863PubMedCrossRefGoogle Scholar
  65. 65.
    Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the Preventive Services Task Force. Ann Intern Med 2002; 136: 765–776PubMedGoogle Scholar
  66. 66.
    Whyte EM, Mulsant BH. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 2002; 52 (3): 253–264PubMedCrossRefGoogle Scholar
  67. 67.
    deGroot M, Anderson R, Freedland KE, et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63: 619–630Google Scholar
  68. 68.
    DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Int Med 2000; 160 (14): 2101–2107CrossRefGoogle Scholar
  69. 69.
    Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003; 54: 216–226PubMedCrossRefGoogle Scholar
  70. 70.
    Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes. Arch Intern Med 2000; 160: 3278–3285PubMedCrossRefGoogle Scholar
  71. 71.
    Lin E, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004; 27 (9): 2154–2160PubMedCrossRefGoogle Scholar
  72. 72.
    Kessler RC, Foster CL, Saunders WB, et al. Social consequences of psychiatric disorders: I. Educational attainment. Am J Psych 1995; 152 (7): 1026–1032Google Scholar
  73. 73.
    Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 18 Aug 1989; 262 (7): 914–919CrossRefGoogle Scholar
  74. 74.
    Simon GE, Barber C, Birnbaum HG, et al. Depression and work productivity: the comparative costs of treatment versus non-treatment. J Occup Environ Med 2001; 43 (1): 2–9PubMedCrossRefGoogle Scholar
  75. 75.
    Ettner SL, Frank RG, Kessler RC. The impact of psychiatric disorders on labor market outcomes. Ind Labor Relat Rev 1997; 54: 64–81CrossRefGoogle Scholar
  76. 76.
    Kessler RC, Greenberg PE, Mickelson KD, et al. The effects of chronic medical conditions on work loss and work cutback. J Occup Environ Med 2001; 43: 218–225PubMedCrossRefGoogle Scholar
  77. 77.
    Ormel J, Von Korff M, Ustun TB, et al. Common mental disorders and disability across cultures: results from the WHO collaborative study on psychological problems in general health care. JAMA 1994; 272: 1741–1748PubMedCrossRefGoogle Scholar
  78. 78.
    Wang PS, Beck AL, Berglund P, et al. Effects of major depression on moment-in-time work performance. Am J Psych 2004; 161: 1885–18891CrossRefGoogle Scholar
  79. 79.
    Von Korff M, Katon W, Unutzer J, et al. Improving depression care: barriers, solutions, and research needs. J Fam Pract 2001; 50 (6): 529–530Google Scholar
  80. 80.
    Thomas CM, Morris S. Cost of depression among adults in England in 2000. Br J Psychiatry 2003; 183: 514–519PubMedCrossRefGoogle Scholar
  81. 81.
    Hu T. The economic burden of depression and reimbursement policy in the Asia Pacific region. Australas Psychiatry 2004; 12 Suppl. 1: S11–S15PubMedCrossRefGoogle Scholar
  82. 82.
    Wulsin L, Vaillant G, Wells KB. A systematic review of the mortality of depression. Psychosom Med 1999; 61: 6–17PubMedGoogle Scholar
  83. 83.
    Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res 2003; 12 (1): 22–23PubMedCrossRefGoogle Scholar
  84. 84.
    Peele PB, Tollerud DJ. Depression and occupational injury: results of a pilot investigation. J Occup Environ Med 2005; 47: 424–427PubMedCrossRefGoogle Scholar
  85. 85.
    Heru AM, Ryan CE. Burden, reward and family functioning of caregivers for relatives with mood disorders: 1-year follow-up. J Affect Disord 2004; 83: 221–225PubMedCrossRefGoogle Scholar
  86. 86.
    DeLeire T, Manning W. Labor market costs of illness: prevalence matters. Health Econ 2004; 13: 239–250PubMedCrossRefGoogle Scholar
  87. 87.
    Birnbaum HG, Leong SA, Greenberg PE. The economics of women and depression: an employer’s perspective. J Affect Disord 2003; 74: 15–22PubMedCrossRefGoogle Scholar
  88. 88.
    Kessler RC, Frank RG. The impact of psychiatric disorders on work loss days. Psychol Med 1997; 27: 218–225Google Scholar
  89. 89.
    Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 1998; 279: 526–531PubMedCrossRefGoogle Scholar
  90. 90.
    Olfson M, Marcus S, Druss B, et al. National trends in the outpatient treatment of depression. JAMA 2002; 287: 203–209PubMedCrossRefGoogle Scholar
  91. 91.
    Wittchen HU, Pittrow D. Prevalence, recognition and management of depression in primary care in Germany: the Depression 2000 study. Hum Psychopharmacol 2002; (17): S1–S16PubMedCrossRefGoogle Scholar
  92. 92.
    ESEMeD/MHEDEA 2000 investigators. Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004; 109 Suppl. 420: 47–54CrossRefGoogle Scholar
  93. 93.
    Wang PS, Lane M, Olfson M, et al. Twelve-month use of mental health services in the US. Arch Gen Psych 2005; 62: 629–640CrossRefGoogle Scholar
  94. 94.
    Gandjour A, Telzerow A, Lauterbach W. Costs and quality in the treatment of acute depression in primary care: a comparison between England, Germany and Switzerland. Int Clin Psychopharmacol 2004; 19 (4): 201–208PubMedCrossRefGoogle Scholar
  95. 95.
    Horvitz-Lennon M, Normand S, Frank RG, et al. Usual care for major depression in the 1990s: characteristics and expert-estimated outcomes. Am J Psychiatry 2003; 160: 720–726PubMedCrossRefGoogle Scholar
  96. 96.
    Gilbody S, Whitty P, Grimshaw J, et al. Educational and organizational interventions to improve the management of depression in primary care. JAMA 2003; 289: 3145–3151PubMedCrossRefGoogle Scholar
  97. 97.
    Badamgarav E, Weingarten SR, Henning JM, et al. Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry 2003; 160 (12): 2080–2090PubMedCrossRefGoogle Scholar
  98. 98.
    Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996; 74: 511–544PubMedCrossRefGoogle Scholar
  99. 99.
    Callahan CM, Kroenke K, Counsell SR, et al. Treatment of depression improves physical functioning in older adults. J Am Geriatr Soc 2005; 53: 367–373PubMedCrossRefGoogle Scholar
  100. 100.
    Williams Jr JW, Katon W, Lin EHB, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Int Med 2004; 140 (12): 1015–1024PubMedGoogle Scholar
  101. 101.
    Lin EHB, Katon W, Von Korff M, et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis. JAMA 2003; 290 (18): 2428–2434PubMedCrossRefGoogle Scholar
  102. 102.
    Writing Committee. Effects of treating depression and low perceived social support on clinical events after myocardial infarction. JAMA 2003; 289: 3106–3116CrossRefGoogle Scholar
  103. 103.
    Barr Taylor C, Youngblood ME, Cagtellier D, et al., for the ENRICHED investigators. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psych 2005; 62: 792–798CrossRefGoogle Scholar
  104. 104.
    Glassman A, O’Connor C, Califf R, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288 (6): 701–709PubMedCrossRefGoogle Scholar
  105. 105.
    Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work. Arch Gen Psych 1992; 49: 761–768CrossRefGoogle Scholar
  106. 106.
    Berndt ER, Finkelstein SN, Greenberg PE, et al. Workplace performance effects from chronic depression and its treatment. J Health Econ 1998; 17: 511–535PubMedCrossRefGoogle Scholar
  107. 107.
    Simon GE, Revicki D, Heiligenstein J, et al. Recovery from depression, work productivity, and health care costs among primary care patients. Gen Hosp Psychiatry 2000; 22: 153–162PubMedCrossRefGoogle Scholar
  108. 108.
    McCulloch J, Ozminkowski RJ, Cuffel B, et al. Analysis of a managed psychiatric disability program. J Occup Environ Med 2001; 43 (2): 101–109PubMedCrossRefGoogle Scholar
  109. 109.
    Soutere E, Lozet H, Cimarosti I. Predicting factors for absenteeism in patients with major depressive disorders. Eur J Epidemiol 1997; 13: 87–93CrossRefGoogle Scholar
  110. 110.
    Von Korff M, Ormel J, Katon W, et al. Disability and depression among high utilizers of health care. Arch Gen Psychiatry 1992; 49: 91–100CrossRefGoogle Scholar
  111. 111.
    Simon GE, Chisholm D, Treglia M, et al. Course of depression, health services costs, and work productivity in an international primary care study. Gen Hosp Psychiatry 2002; 24: 328–335PubMedCrossRefGoogle Scholar
  112. 112.
    Simon GE, Katon W, Rutter C, et al. Impact of improved depression treatment in primary care on daily functioning and disability. Psychological Med 1998; 28 (3): 693–701CrossRefGoogle Scholar
  113. 113.
    Von Korff M, Katon W, Rutter CM, et al. Effect on disability outcomes of a depression relapse prevention program. Psychosom Med 2003; 65: 938–943CrossRefGoogle Scholar
  114. 114.
    Pincus HA, Pechura CM, Elinson L, et al. Depression in primary care: linking clinical and systems strategies. Gen Hosp Psychiatry 2001; 23: 311–318PubMedCrossRefGoogle Scholar
  115. 115.
    Nutting PA, Rost K, Dickinson M, et al. Barriers to initiating depression treatment in primary care practice. J Gen Intern Med 2002; 17: 103–111PubMedCrossRefGoogle Scholar
  116. 116.
    Baik S, Bowers BJ, Oakley LD, et al. The recognition of depression: the primary care clinician’s perspective. Ann Fam Med 2005; 3: 31–37PubMedCrossRefGoogle Scholar
  117. 117.
    Frank RG. Huskamp HA, Pincus HA. Aligning incentives in the treatment of depression in primary care with evidence based practice. Psychiatr Serv 2003; 54 (5): 682–687PubMedCrossRefGoogle Scholar
  118. 118.
    Kilbourne AM, Schulberg HC, Post EP, et al. Translating evidence-based depression management services to community-based primary care practices. Milbank Q 2004; 82 (4): 631–659PubMedCrossRefGoogle Scholar
  119. 119.
    Schoenbaum M, Kelleher K, Lave JR, et al. Exploratory evidence on the market for effective depression care in Pittsburgh. Psychiatr Serv 2004; 55 (4): 392–395PubMedCrossRefGoogle Scholar
  120. 120.
    Simon GE, Von Korff M, Wagner EH, et al. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 1993; 15: 399–408PubMedCrossRefGoogle Scholar
  121. 121.
    Sturm R. The myth of the medical cost offset. Psychiatr Serv 2001; 52 (6): 738–740PubMedCrossRefGoogle Scholar
  122. 122.
    Goldman HH. Justifying mental health care costs. Health Aff 1999; 18 (2): 94–95CrossRefGoogle Scholar
  123. 123.
    Pirraglia PA, Rosen AB, Hermann RC, et al. Cost-utility analysis studies of depression management: a systematic review. Am J Psychiatry 2004; 161 (12): 2155–2162PubMedCrossRefGoogle Scholar
  124. 124.
    Laupacis A, Feeny D, Detsky A, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992; 146 (4): 473–481Google Scholar
  125. 125.
    Unutzer J, Katon WJ, Russo J, et al. Willingness to pay for depression treatment in primary care. Psychiatr Serv 2003; 54 (3): 340–345PubMedCrossRefGoogle Scholar
  126. 126.
    Frank HG, McGuire TG, Normand LT, et al. The value of mental health care at the system level: the case of treating depression. Health Aff 1999; 18 (5): 71–88CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2007

Authors and Affiliations

  1. 1.Department of Health Policy and Management, Graduate School of Public HealthUniversity of PittsburghPittsburghUSA
  2. 2.Department of PsychiatryColumbia UniversityNew YorkUSA
  3. 3.New York Presbyterian HospitalNew YorkUSA
  4. 4.RAND CorporationPittsburghUSA

Personalised recommendations